Related Experiment Videos
AFP isoforms and their clinical significance (overview)
1Medical Department II, Klinikum Grosshadern, University of Munich, Germany.
Anticancer Research
|July 1, 1997
Summary
Investigating Alpha-fetoprotein (AFP) lectin binding aids in distinguishing AFP sources and malignancies. This method helps differentiate AFP in liver diseases, hepatocellular cancer (HCC), and yolk sac tumors (YST).
Area of Science:
- Biochemistry
- Oncology
- Clinical Chemistry
Background:
- Alpha-fetoprotein (AFP) is a crucial tumor marker for germ cell tumors (YST) and hepatocellular cancer (HCC).
- AFP's specificity is limited by elevations in benign liver diseases (BLD) and pregnancy.
- Differentiating AFP sources is vital for accurate diagnosis.
Purpose of the Study:
- To explore the utility of AFP lectin binding for differentiating AFP sources and associated diseases.
- To evaluate the effectiveness of specific lectins in distinguishing between various conditions causing AFP elevation.
Main Methods:
- Affinity electrophoresis and chromatography using lectins such as Concanavalin A and Lens culinaris agglutinin (LCA).
- Characterization of AFP reactive patterns using a panel of lectins, including erythroagglutinating E-PHA.
- Review of data on LCA and E-PHA for liver AFP differentiation.
Main Results:
- Successful differentiation of AFP sources and diseases using lectin binding patterns.
- Identification of four distinct reactive patterns corresponding to cord serum/liver/BLD, HCC, gastrointestinal tumors, and YST.
- Demonstrated clinical importance of LCA and E-PHA in differentiating liver AFP.
Conclusions:
- AFP lectin binding analysis is a valuable tool for clarifying unexplained AFP elevations.
- This method aids in distinguishing the origin of AFP and identifying malignancy.
- Lectin-based AFP characterization enhances diagnostic accuracy for liver cancer and other conditions.